<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Little is known about referrals from primary care providers (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e>) for suspected <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>, including their clinical triggers and frequency </plain></SENT>
<SENT sid="1" pm="."><plain>A random sample of 190 Massachusetts <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> were presented with a vignette concerning a patient with a new finding of moderate <z:hpo ids='HP_0001903'>anemia</z:hpo>, asked how they would respond, and then asked what they would do if the patient returned with persistent <z:hpo ids='HP_0001903'>anemia</z:hpo> plus one additional sign or symptom </plain></SENT>
<SENT sid="2" pm="."><plain>We also asked about referral behaviors for suspected <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> during the prior year </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 134 (70.5%) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> responded </plain></SENT>
<SENT sid="4" pm="."><plain>At first <z:hpo ids='HP_0001903'>anemia</z:hpo> presentation,only 3.8% reported referring to hematology </plain></SENT>
<SENT sid="5" pm="."><plain>The development of a second sign or symptom yielded higher referral rates: <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> 588.7%, <z:hpo ids='HP_0001882'>leukopenia</z:hpo> 5 63.9%, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> 5 63.9%, <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> 5 42.9%, <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> 5 37.6%, night sweats 5 25.6%, and <z:hpo ids='HP_0001824'>weight loss</z:hpo> 5 23.3% </plain></SENT>
<SENT sid="6" pm="."><plain>The median yearly number (interquartile range) of patients <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> reported suspecting of having <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e> was 5 (3, 10), and the median formally referred was 5 (3, 10) </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that <z:hpo ids='HP_0001903'>anemia</z:hpo> plus signs and symptoms suggestive of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> or <z:hpo ids='HP_0001909'>leukemia</z:hpo> (compared with those suggestive of <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) are more likely to prompt hematology referral </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, given their rarity,the numbe </plain></SENT>
</text></document>